An Appropriate Use of Accelerated Approval - Aducanumab for Alzheimer's Disease
- PMID: 34320283
- DOI: 10.1056/NEJMc2111960
An Appropriate Use of Accelerated Approval - Aducanumab for Alzheimer's Disease
Comment on
- 
  
  Revisiting FDA Approval of Aducanumab.N Engl J Med. 2021 Aug 26;385(9):769-771. doi: 10.1056/NEJMp2110468. Epub 2021 Jul 28. N Engl J Med. 2021. PMID: 34320282 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Medical
 
        